Performing gynecologic cancer surgery during the COVID‐19 pandemic in Turkey: A multicenter retrospective observational study

Objective To report the perioperative outcomes of 200 patients with gynecologic cancer who underwent surgery during the Novel Coronavirus Disease (COVID‐19) pandemic and the safety of surgical approach. Methods Data of patients operated between March 10 and May 20, 2020, were collected retrospective...

Full description

Saved in:
Bibliographic Details
Published in:International journal of gynecology and obstetrics 2020-10, Vol.151 (1), p.33-38
Main Authors: Dursun, Polat, Dervisoglu, Haluk, Daggez, Mine, Turan, Taner, Kiliç, Fatih, Tekin, Özlem M., Üreyen, Işin, Toptaş, Tayfun, Demirayak, Gökhan, Önder, Ayşe B., Çelik, Çetin, Bayramoğlu, Denizhan, Guzel, Ahmet B., Arioz, Dagistan T., Bilir, Filiz, Ozdemir, Isa A., Tasci, Tolga, Karalok, Alper, Karateke, Ateş
Format: Article
Language:English
Subjects:
Adult
Clinical
COVID-19 - epidemiology
COVID-19 - surgery
COVID‐19
Female
Genital Neoplasms, Female - pathology
Gynecologic surgical procedures
Gynecologic Surgical Procedures - statistics & numerical data
Humans
Lymph node excision
Middle Aged
Ovarian neoplasms
Postoperative Complications - epidemiology
Retrospective Studies
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Turkey
Urogenital Neoplasms - epidemiology
Urogenital Neoplasms - surgery
Uterine cervical neoplasms
Uterine neoplasms
Vulvar neoplasms
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To report the perioperative outcomes of 200 patients with gynecologic cancer who underwent surgery during the Novel Coronavirus Disease (COVID‐19) pandemic and the safety of surgical approach. Methods Data of patients operated between March 10 and May 20, 2020, were collected retrospectively. Data were statistically analyzed using IBM Statistical Package for the Social Sciences (SPSS) Statistics for Windows v. SP21.0. Results Data of 200 patients were included. Their mean age was 56 years. Of the patients, 54% (n=108), 27.5% (n=55), 12.5% (n=25), and 2% (n=4) were diagnosed as having endometrial, ovarian, cervical, and vulvar cancer, respectively. Of them, 98% underwent non‐emergent surgery. A minimally invasive surgical approach was used in 18%. Stage 1 cancer was found in 68% of patients. Surgeons reported COVID‐related changes in 10% of the cases. The rate of postoperative complications was 12%. Only two patients had cough and suspected pneumonic lesions on thoracic computed tomography postoperatively, but neither was positive for COVID‐19 on polymerase chain reaction testing. Conclusion Based on the present findings, it is thought that gynecologic cancer surgery should continue during the COVID‐19 pandemic while adhering to the measures. Postponement or non‐surgical management should only be considered in patients with documented infection. Gynecologic cancer surgery should continue during the COVID‐19 pandemic while adhering to measures. Only 1% of patients developed COVID‐19‐related symptoms during the postoperative follow‐up period. Gynecologic cancer surgery should continue during the COVID‐19 pandemic while adhering to measures. Only 1% of patients developed COVID‐19‐related symptoms during the postoperative follow‐up period.
ISSN:0020-7292
1879-3479
DOI:10.1002/ijgo.13296